Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189814 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von David Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Viral, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
There is a need to investigate novel strategies in order to create an effective, broadly protective vaccine for current and future severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks. The currently available vaccines demonstrate compromised efficacy against emerging SARS-CoV-2 variants of concern (VOCs), short-lived immunity, and susceptibility to immune imprinting due to frequent boosting practices. In this study, we examined the specificity of cross-reactive IgG antibody responses in mRNA-vaccinated, AstraZeneca-vaccinated, and unvaccinated donors to identify potentially conserved, cross-reactive epitopes to target in order to create a broadly protective SARS-CoV-2 vaccine. Our study provides evidence for cross-reactive IgG antibodies specific to eight different spike (S) variants. Furthermore, the specificities of these cross-variant IgG antibody titers were associated to some extent with spike S1- and S2-subunit-derived epitopes P1 and P2, respectively. In addition, nucleocapsid (N)- and membrane (M)-specific IgG antibody titers correlated with N- and M-derived epitopes conserved across beta-CoVs, P3–7. This study reveals conserved epitopes of viral antigens, targeted by natural and/or vaccine-induced human immunity, for future designs of next-generation COVID-19 vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.
- Department of Medicine, Faculty of Medicine and Dentistry, College of Health Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.
ORCID-Profile: Alex Herchen, Bruce Ritchie, Babita Agrawal
Förderung
- CIHR
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Yao, D., Patel, R. S., Lam, A., Glover, Q., Srinivasan, C., Herchen, A., Ritchie, B., & Agrawal, B. (2024). Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189814
Vancouver
Yao D, Patel RS, Lam A, Glover Q, Srinivasan C, Herchen A, et al. Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189814
BibTeX
@article{Yao2024,
author = {Yao, David and Patel, Raj S and Lam, Adrien and Glover, Quarshie and Srinivasan, Cindy and Herchen, Alex and Ritchie, Bruce and Agrawal, Babita},
title = {Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189814}
}
EUVIMED